Cite
MLA Citation
C. Harrison et al.. “P1054: MYLOX-1: AN OPEN-LABEL, PHASE IIA STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR, GB2064, IN MYELOFIBROSIS.” HemaSphere, vol. 6, n.d., pp. 944–945. http://access.bl.uk/ark:/81055/vdc_100159757346.0x000014